Carisma Therapeutics, Inc. (CARM)
USD 0.46
(-1.62%)
USD 0.46
(-1.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -81.32 Million | -7.56 Million | -37.32 Million | -27.01 Million | -37.52 Million | -22.82 Million |
| Net Income | -86.87 Million | -61.22 Million | -40.78 Million | -28.34 Million | -107.5 Million | -33.69 Million |
| Depreciation & Amortization | 8.26 Million | 6.09 Million | 682 Thousand | 448 Thousand | 219 Thousand | 208 Thousand |
| Deferred income taxes | -2.19 Million | 21.74 Million | - | - | -1.14 Million | - |
| Stock-based compensation | 2.31 Million | 275 Thousand | 479 Thousand | 163 Thousand | - | - |
| Change in working capital | -5.43 Million | 45.19 Million | 1.46 Million | -453 Thousand | -3.09 Million | 578 Thousand |
| Other non-cash items | 2.6 Million | -19.64 Million | 834 Thousand | 1.17 Million | 72.76 Million | 10.03 Million |
| Investing Cash Flow | 72.4 Million | -32.56 Million | -1.87 Million | -440 Thousand | -136 Thousand | -2000.00 |
| Investments in PPE | -1.13 Million | -4.66 Million | -1.87 Million | -440 Thousand | -136 Thousand | -2000.00 |
| Acquisitions | -73.54 Million | 30 Thousand | - | - | - | - |
| Investment purchases | -34.46 Million | -90.9 Million | - | - | - | - |
| Sales/Maturities of investments | 108 Million | 63 Million | - | - | - | - |
| Other Investing Activities | 73.54 Million | -30 Thousand | - | - | - | - |
| Financing Cash Flow | 62.32 Million | 35.76 Million | 15.96 Million | 72.25 Million | 35.35 Million | 58.58 Million |
| Debt repayment | -1.3 Million | -865 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 30.82 Million | 35.1 Million | 176.13 Million | 38.11 Million | 35.35 Million | 58.58 Million |
| Other Financing Activities | 32.79 Million | 1.52 Million | -160.16 Million | 34.14 Million | - | 277 Thousand |
| Accounts receivables | - | 23.66 Million | -24.49 Million | - | - | - |
| Accounts payables | 2.19 Million | -473 Thousand | -974 Thousand | 1.28 Million | 535 Thousand | 460 Thousand |
| Inventory | - | -23.66 Million | 24.49 Million | - | - | - |
| Other working capital | -7.62 Million | 45.66 Million | 2.43 Million | -1.73 Million | -3.63 Million | 117.99 Thousand |
| Cash at beginning of period | 24.19 Million | 162.63 Million | 51.78 Million | 6.98 Million | 50.42 Million | 14.68 Million |
| Cash at end of period | 77.6 Million | 24.19 Million | 28.55 Million | 51.78 Million | 48.12 Million | 50.42 Million |
| Capital Expenditure | -1.13 Million | -4.66 Million | -1.87 Million | -440 Thousand | -136 Thousand | -2000.00 |
| Effect of forex changes on cash | - | -162.49 Million | - | - | - | - |
| Net cash flow / Change in cash | 53.41 Million | -138.44 Million | -23.23 Million | 44.8 Million | -2.3 Million | 35.74 Million |
| Free Cash Flow | -82.45 Million | -12.22 Million | -39.19 Million | -27.45 Million | -37.65 Million | -22.83 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.16 Million | -18.97 Million | -20.95 Million | -86.87 Million | -21.4 Million | -19.87 Million |
| Depreciation & Amortization | 255 Thousand | 1.69 Million | 2.08 Million | 8.26 Million | 695 Thousand | 715 Thousand |
| Deferred income taxes | - | - | -3.22 Million | -2.19 Million | -172 Thousand | -406 Thousand |
| Stock-based compensation | 625 Thousand | 1.05 Million | 873 Thousand | 2.31 Million | 848 Thousand | 330 Thousand |
| Change in working capital | -8.96 Million | -7.86 Million | 2.08 Million | -5.43 Million | -2.39 Million | -691 Thousand |
| Other non-cash items | 4.33 Million | 7.93 Million | 2.89 Million | 2.6 Million | 1.43 Million | 1.38 Million |
| Investing Cash Flow | -106 Thousand | -17 Thousand | 10.43 Million | 72.4 Million | 29.81 Million | 35.75 Million |
| Investments in PPE | -106 Thousand | -17 Thousand | -561 Thousand | -1.13 Million | -189 Thousand | -247 Thousand |
| Acquisitions | - | - | -3.46 Million | -73.54 Million | - | - |
| Investment purchases | - | - | - | -34.46 Million | - | - |
| Sales/Maturities of investments | - | - | 11 Million | 108 Million | 30 Million | 36 Million |
| Other Investing Activities | - | - | 11 Million | 73.54 Million | 30 Million | 36 Million |
| Financing Cash Flow | 73 Thousand | 1.35 Million | 247 Thousand | 62.32 Million | -2.03 Million | -3.63 Million |
| Debt repayment | -413 Thousand | -1.31 Million | -150 Thousand | -1.3 Million | -938 Thousand | -107 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 2000.00 | 2.28 Million | 95 Thousand | 30.82 Million | 40 Thousand | 52 Thousand |
| Other Financing Activities | -342 Thousand | 383 Thousand | 156 Thousand | 32.79 Million | -1.13 Million | -3.57 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -74 Thousand | -1.82 Million | 1.81 Million | 2.19 Million | -287 Thousand | -2.16 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -8.89 Million | -6.03 Million | 270.99 Thousand | -7.62 Million | -2.11 Million | 1.47 Million |
| Cash at beginning of period | 56.51 Million | 77.6 Million | 83.13 Million | 24.19 Million | 76.38 Million | 62.8 Million |
| Cash at end of period | 40.36 Million | 56.51 Million | 77.6 Million | 77.6 Million | 83.16 Million | 76.38 Million |
| Capital Expenditure | -106 Thousand | -17 Thousand | -561 Thousand | -1.13 Million | -189 Thousand | -247 Thousand |
| Effect of forex changes on cash | - | - | 29.99 Thousand | - | - | - |
| Net cash flow / Change in cash | -16.15 Million | -21.09 Million | -5.52 Million | 53.41 Million | 6.77 Million | 13.57 Million |
| Free Cash Flow | -16.22 Million | -22.44 Million | -16.8 Million | -82.45 Million | -21.18 Million | -18.79 Million |
SYBE
SELF
NTW
OLCLF
601933
MINT